Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intensity Therapeutics, Inc. - Common Stock (NQ:INTS)

0.5658 -0.3343 (-37.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,207,733
Open 0.6500
Bid (Size) 0.5780 (2)
Ask (Size) 0.5990 (25)
Prev. Close 0.9001
Today's Range 0.5500 - 0.6500
52wk Range 0.5500 - 5.275
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Get insights into the top gainers and losers of Friday's after-hours session.
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga

Performance

YTD
-67.7%
-67.7%
1 Month
-72.3%
-72.3%
3 Month
-76.7%
-76.7%
6 Month
-82.7%
-82.7%
1 Year
-85.6%
-85.6%

More News

Read More
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Intensity Therapeutics (INTS) Stock Is Getting Hammered
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
INTS Stock Earnings: Intensity Therapeutics Misses EPS for Q2 2024
Via InvestorPlace
INTS Stock Earnings: Intensity Therapeutics Reported Results for Q1 2024
Via InvestorPlace
INTS Stock Earnings: Intensity Therapeutics Beats EPS for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Dow Jumps Over 100 Points; MBIA Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities

Frequently Asked Questions

Is Intensity Therapeutics, Inc. - Common Stock publicly traded?
Yes, Intensity Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Intensity Therapeutics, Inc. - Common Stock trade on?
Intensity Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Intensity Therapeutics, Inc. - Common Stock?
The ticker symbol for Intensity Therapeutics, Inc. - Common Stock is INTS on the Nasdaq Stock Market
What is the current price of Intensity Therapeutics, Inc. - Common Stock?
The current price of Intensity Therapeutics, Inc. - Common Stock is 0.5658
When was Intensity Therapeutics, Inc. - Common Stock last traded?
The last trade of Intensity Therapeutics, Inc. - Common Stock was at 04/25/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.